‹ All stocks
Forte Biosciences
FBRX · NASDAQ · Healthcare
$76.99
▲ $0.02 (0.03%)
Not enough price history yet for this range.
Day range
$76.96 – $77.00
Year range
$10.30 – $77.20
Open
$76.97
Previous close
$76.97
Market cap
$1.58B
Volume (24h)
$1.4M
Volume (52w)
$107.78M
Performance
7D
— 0.00%
1M
— 0.00%
3M
▲ 277.22%
6M
▲ 191.19%
1Y
▲ 430.23%
YTD
▲ 226.09%
3Y
▲ 397.35%
5Y
▲ 4.04%
All-time
▼ -98.35%
Key statistics
P/E ratio
-15.71
EPS (TTM)
$-4.90
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
20.5M
About Forte Biosciences
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1139.65 | -1.23% |
JNJ Johnson & Johnson |
$256.11 | -1.42% |
ABBV AbbVie |
$260.91 | 0.45% |
MRK Merck & Co. |
$143.38 | -0.27% |
UNH UnitedHealth Group Incorp… |
$368.09 | 0.81% |